Third Paediatric Expert Patients Training Workshop

TEDDY is organising the “Third Paediatric Expert Patients Training Workshop” in collaboration with EURORDIS and the Sant Joan de Déu Research Foundation in the framework of the European Joint Programme on Rare Diseases (EJPRD).   This year, the paediatric training workshop will take place in Barcelona, Spain, from Wednesday 21st to Friday 23rd June 2023.  This

April 26th, 2023|

TEDDY Kids meeting dedicated to Rare Diseases 

  This 28 February is Rare Disease Day (RDD), an opportunity to celebrate people living with rare diseases and to raise awareness of these disorders.   TEDDY Network, through its Young Persons Advisory Groups (YPAGs) (KIDS Albania, KIDS Bari, and KIDS Hellas) and the TEDDY Kids international group, is happy to participate in several activities planned to raise

February 20th, 2023|

Actions to support the development of medicines for children

The closing report of the European Medicines Agency (EMA) and European Commission (DG Health and Food Safety) action plan on paediatrics has been recently published.   During the past four years, several initiatives were taken to increase the efficiency of the paediatric regulatory processes and promote the development of paediatric medicines.  The paediatric action plan has

February 20th, 2023|

COVID’s Lasting Consequences for Kids

Dr. Jeremy Faust, editor-in-chief of MedPage Today has interviewed Dr. Zachary Rubin, allergist and immunologist of Oak Brook Allergists in Illinois, to discuss the lasting effects of COVID-19 on pediatric health.  According to Dr. Rubin there is not a single clinical phenotype for patients with long COVID. Patients can present:   brain fog and other neurological

January 26th, 2023|

Workshop on quality criteria/standards of paediatric clinical trial sites

The workshop, co-organised by the European network of paediatric research at the EMA (Enpr-EMA) and conect4children (c4c), was held virtually on October 3, 2022. Participants included members of Enpr-EMA and of c4c, members of the European Medicines Agency’s (EMA) Paediatric Committee (PDCO) as well as members of EMA’s Paediatric Medicines Office, along with invitees representing

January 13th, 2023|

Becoming a Leader: Donato Bonifazi on ‘Managing Trials’

Dr Donato Bonifazi, in his role as iCAN Advisory Board Member, has participated in the International Children’s Advisory Network (iCAN), “Becoming a Leader” short videos series to talk about the challenges of conducting clinical trials for and with the paediatric population.   According to Dr Bonifazi “we’ll not only need to adapt adults' medicines to

January 13th, 2023|

Adolescent Inclusion Decision Tree

The European Forum for Good Clinical Practice (EFGCP) Children’s Medicines Working Party (CMWP) has developed an open-access “Adolescent Inclusion Decision Tree” to be used by trial sponsors, trial investigators, IRBs/ethics committees, and health regulatory agencies, when a trial with age-inclusive trial design is being explored, developed or reviewed.   The tool outlines over-arching principles for consideration,

January 11th, 2023|

Project MADAM (Model Adjusted Doses for All Mothers)

Project MADAM (Model Adjusted Doses for All Mothers) is a collaboration between Radboud UMC and Maastricht University Medical Centres in the Netherlands and the Dutch Teratology Information Service (Lareb) with funding from the Gates Foundation that addresses the gap of knowledge and limited information on medication doses in pregnancy.  In particular, this project aims to

November 3rd, 2022|

Reducing long-term complications in preterm infants

In a new study, a team of researchers from Inserm, University Hospital Lille, and Université de Lille at the Lille Neuroscience and Cognition laboratory has opened up interesting avenues to improve the prognosis of preterm infants.   By conducting research into congenital hypogonadotropic hypogonadism, scientists have discovered the key role that nitric oxide synthase (NOS1) plays

November 3rd, 2022|